I've seen this plenty times b4. Someone buys into it b4 the recommendation, then they sell into the high volume. price settles around their target and hopefully the company will bring out an announcement shortly and everyone's happy. positive is a whole lot of new investors just got introduced into orthocell. hopefully there in it for the long term.
Ann: First Human Tendons Grown in Laboratory, page-30
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.45M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 37.0¢ | $34.15K | 92.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 60000 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 107235 | 4 |
View Market Depth
| Last trade - 10.07am 10/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |